The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline

Cognitive decline is one of the most feared aspects of aging, and understanding how to protect the nervous system at the genetic level is a critical research frontier. This study by Pickart, Vasquez-Soltero, and Margolina, published in Brain Sciences, investigated how GHK influences gene expression specifically related to neurological health and cognitive function.

The researchers utilized the Broad Institute's Connectivity Map to analyze over 700 genes associated with nerve cells and neurological function. They examined which of these genes were modulated by GHK treatment, mapping the results to known pathways involved in neuroprotection, neurodegeneration, and cognitive function.

The findings were impressive: GHK modulates approximately 31% of human genes with changes of 50% or greater, and many of these are directly relevant to nervous system function and neurodegeneration. The peptide demonstrated stimulating and growth-promoting effects on neurons and glial cells, enhanced antioxidant defenses, improved DNA repair capacity, and reduced inflammatory signaling. Critically, the researchers also documented that human plasma GHK levels decline significantly with age — from 200 ng/ml in healthy young adults to just 80 ng/ml in older individuals.

This study establishes an important connection between GHK-Cu supplementation and brain health. The age-related decline in natural GHK levels may contribute to the vulnerability of the nervous system to degeneration and cognitive impairment. By restoring GHK levels through supplementation, it may be possible to support the gene expression patterns that protect neurons and maintain cognitive function into later life.